ASG Stock Overview
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada.
Aurora Spine Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.40|
|52 Week High||CA$0.80|
|52 Week Low||CA$0.22|
|1 Month Change||-5.95%|
|3 Month Change||64.58%|
|1 Year Change||-49.36%|
|3 Year Change||9.72%|
|5 Year Change||139.39%|
|Change since IPO||-70.74%|
Recent News & Updates
Health Check: How Prudently Does Aurora Spine (CVE:ASG) Use Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
|ASG||CA Medical Equipment||CA Market|
Return vs Industry: ASG underperformed the Canadian Medical Equipment industry which returned -39.3% over the past year.
Return vs Market: ASG underperformed the Canadian Market which returned 4.8% over the past year.
|ASG Average Weekly Movement||16.3%|
|Medical Equipment Industry Average Movement||13.0%|
|Market Average Movement||9.9%|
|10% most volatile stocks in CA Market||16.9%|
|10% least volatile stocks in CA Market||4.3%|
Stable Share Price: ASG is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 16% a week.
Volatility Over Time: ASG's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures.
Aurora Spine Fundamentals Summary
|ASG fundamental statistics|
Is ASG overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ASG income statement (TTM)|
|Cost of Revenue||US$5.71m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.035|
|Net Profit Margin||-22.37%|
How did ASG perform over the long term?See historical performance and comparison
Is Aurora Spine undervalued compared to its fair value and its price relative to the market?
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate ASG's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate ASG's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: ASG is unprofitable, so we can't compare its PE Ratio to the North American Medical Equipment industry average.
PE vs Market: ASG is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ASG's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ASG is good value based on its PB Ratio (3.7x) compared to the CA Medical Equipment industry average (4.7x).
How is Aurora Spine forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Aurora Spine has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Aurora Spine performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ASG is currently unprofitable.
Growing Profit Margin: ASG is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ASG is unprofitable, but has reduced losses over the past 5 years at a rate of 14.5% per year.
Accelerating Growth: Unable to compare ASG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ASG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.1%).
Return on Equity
High ROE: ASG has a negative Return on Equity (-42.36%), as it is currently unprofitable.
How is Aurora Spine's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: ASG's short term assets ($8.4M) exceed its short term liabilities ($2.6M).
Long Term Liabilities: ASG's short term assets ($8.4M) exceed its long term liabilities ($2.4M).
Debt to Equity History and Analysis
Debt Level: ASG has more cash than its total debt.
Reducing Debt: ASG's debt to equity ratio has increased from 33.9% to 41% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ASG has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ASG has less than a year of cash runway if free cash flow continues to grow at historical rates of 21.4% each year.
What is Aurora Spine current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ASG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ASG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ASG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ASG's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ASG has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Trent Northcutt (54 yo)
Mr. Trent J. Northcutt is the Chief Executive Officer and President at Aurora Spine Corporation since February 2012. He is a Founder of Aurora Spine Corporation. Mr. Northcutt served as Vice President at S...
CEO Compensation Analysis
Compensation vs Market: Trent's total compensation ($USD143.04K) is about average for companies of similar size in the Canadian market ($USD168.24K).
Compensation vs Earnings: Trent's compensation has been consistent with company performance over the past year.
Experienced Management: ASG's management team is seasoned and experienced (9.3 years average tenure).
Experienced Board: ASG's board of directors are considered experienced (8.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ASG insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.3%.
Aurora Spine Corporation's employee growth, exchange listings and data sources
- Name: Aurora Spine Corporation
- Ticker: ASG
- Exchange: TSXV
- Founded: 2013
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: CA$26.359m
- Shares outstanding: 66.73m
- Website: https://www.aurora-spine.com
- Aurora Spine Corporation
- 20 Holly Street
- Suite 300
- M4S 3B1
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/21 00:00|
|End of Day Share Price||2022/05/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.